Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDK90
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,275
Award facts
- Contract value 100% obligated
- $98,274.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 5, 2025, by the Defense Logistics Agency (DLA) for Keytruda 100 mg/4 mL vials. The contract, valued at $98,274.72 under a firm fixed-price structure, is scheduled for completion by August 26, 2025, with performance taking place in Park Ridge, Illinois. This delivery order carries no set-aside designation and represents a continuation of DMS Pharmaceutical Group's extensive portfolio supplying pharmaceutical products to federal healthcare facilities.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499.9 million and valid through November 2026. The parent IDC, structured under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. Keytruda, an oncology immunotherapy treatment, aligns with the company's demonstrated capability to deliver specialized pharmaceutical products to federal medical institutions.
Quick answers
Who was awarded contract SPE2DB25FDK90?
SPE2DB25FDK90 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FDK90 worth?
The government has obligated $98,275 on SPE2DB25FDK90.
Is contract SPE2DB25FDK90 an order under another contract?
Yes. SPE2DB25FDK90 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK90 competed?
The extent of competition for SPE2DB25FDK90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award